rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BSX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Boston Scientific appoints new lead independent director and updates executive compensation plans
      Nov 17Investing.comBSX
      Boston Scientific: A Longer Road To Recovery (Rating Downgrade)

      Analyst rates Boston Scientific a Hold: EP and WATCHMAN sales fell 5.3% and 5.9% in Q3, and recovery remains uncertain with 2027 expected to be the trough.

      Nov 17Seeking AlphaBSX
      Is Boston Scientific Still The Business You Bought?
      Nov 16Yahoo FinanceBSX
      Coherent and Boston Scientific have been highlighted as Zacks Bull and Bear of the Day

      Detailed price information for Coreweave Cl A (CRWV-Q) from The Globe and Mail including charting and trades.

      Nov 13The Globe and MailBSX
      Bear of the Day: Boston Scientific (BSX)
      Nov 13Yahoo FinanceBSX
      Boston Scientific Corp. stock underperforms Thursday when compared to competitors
      Nov 12MarketWatchBSX
      Boston Scientific Bets on WATCHMAN Growth Despite Market Slowdown

      BSX bets on WATCHMAN growth through clinical trials and physician outreach, even as slowing demand and rising competition cloud its outlook.

      Nov 12Yahoo FinanceBSX
      Boston Scientific (BSX) Is Back In The Spotlight, What Is Driving Attention?
      Nov 12Yahoo FinanceBSX
      Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls?
      Nov 11Yahoo FinanceBSX
      Boston Scientific Corp. stock outperforms competitors on strong trading day
      Nov 10MarketWatchBSX
      99 Hedge Funds Back This Healthcare Stock: Is It Time to Buy?
      Nov 8Yahoo FinanceBSX
      What Could Go Wrong At Boston Scientific From Here?
      Nov 7Yahoo FinanceBSX
      S&P revises Boston Scientific outlook to negative on franchise pressures

      Investing.com -- S&P Global Ratings has revised its outlook on Boston Scientific Corp. to negative from stable, warning that deepening commercial headwinds across its core product franchises will likely keep financial leverage stretched through 2028. While the rating agency affirmed the medical device maker’s ’A-’ issuer credit rating and senior unsecured debt rating, S&P highlighted that deteriorating top-line momentum coincides with the balance-sheet burden of its pending $14.5 billion acquisi

      Nov 6Yahoo FinanceBSXSPGI
      Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock
      Nov 5Yahoo FinanceBSX
      Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development
      Nov 5Yahoo FinanceBSXBX
      BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays Weak

      Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

      Nov 5The Globe and MailBSX
      Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
      Nov 4BenzingaBSX
      RevMedica Appoints Former Boston Scientific Executive Mike Jones as Chief Executive Officer

      RevMedica, an innovative medical technology company developing intelligent surgical stapling solutions, today announced the appointment of Mike Jones as Chief Executive Officer and a member of its Board of Directors. Jones succeeds RevMedica founder Tom Wenchell, who will transition to President and Chief Operating Officer, continuing to lead product development, technical operations, and day-to-day business execution.

      Nov 4Yahoo FinanceBSX
      BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays Weak
      Nov 4Yahoo FinanceBSX
      Boston Scientific (BSX) Secures $455 Million For A Next Generation Heart Pump
      Nov 4Yahoo FinanceBSX
      Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?

      Detailed price information for Medtronic Inc (MDT-N) from The Globe and Mail including charting and trades.

      Nov 4The Globe and MailBSX
      Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?

      Detailed price information for Medtronic Inc (MDT-N) from The Globe and Mail including charting and trades.

      Nov 3The Globe and MailBSX
      Argus Research Sticks to Its Hold Rating for Boston Scientific (BSX)

      Tipranks Press Release.

      Nov 3The Globe and MailBSX
      Why Did Boston Scientific Stock Jump?
      Nov 3Yahoo FinanceBSX
      Are Wall Street Analysts Bullish on Boston Scientific Stock?
      Nov 3BarchartBSX
      Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
      Nov 3Yahoo FinanceBSXBX
      Medical devices & supplies - diversified stocks Q3 teardown: Boston Scientific (NYSE:BSX) vs the rest

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Nov 3The Globe and MailBSX
      Boston Scientific (BSX) Receives a Hold from Citi

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Nov 3The Globe and MailBSX
      Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock

      CAMBRIDGE, Mass., November 02, 2026--Blackstone Life Sciences ("BXLS") today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The VITALYST system is a next-generation, miniature heart pump intended to increase cardiac output and improve blood flow from the heart to the brain and other vital organs. It is designed to treat acute myocardial infar

      Nov 2Yahoo FinanceBSXBX
      Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and PTC Therapeutics (PTCT)

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Oct 31The Globe and MailPTCTBSX
      Boston Scientific (BSX) Receives a Buy from UBS

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Oct 30The Globe and MailBSX
      Buy, Sell, or Hold? Today’s Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte. Intel, Reddit, Rivian Automotive, and More
      Oct 30Yahoo FinanceDASHHONHONAINCYINTCRIVNBBYBSXGEV
      RBC Capital Sticks to Their Buy Rating for Boston Scientific (BSX)

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Oct 30The Globe and MailBSX
      Oppenheimer downgrades Boston Scientific stock rating on growth concerns
      Oct 30Investing.comBSX
      TD Cowen cuts Boston Scientific stock rating on 2027 outlook
      Oct 30Investing.comBSX
      Cyberattack Fallout Could Be A Game Changer For Boston Scientific (BSX)
      Oct 29Yahoo FinanceBSX
      Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI Push
      Oct 29Yahoo FinanceBSX
      BSX Q3 Earnings Call Flags Growth Challenges Through 2027

      Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

      Oct 29The Globe and MailBSX
      RBC cuts Boston Scientific stock price target on guidance reduction
      Oct 29Investing.comBSX
      What Is Behind The Move In Boston Scientific Stock?
      Oct 29Yahoo FinanceBSX
      Boston Scientific Corp (BSX) (Q3 2026) Earnings Call Highlights: Cyber Incident Slashes Growth ...
      Oct 29Yahoo FinanceBSX
      Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Boston Scientific, eBay, Fervo Energy, Fortinet, Hilton Worldwide Holdings, Lennox International, Palantir Technologies, and More
      Oct 29Yahoo FinanceEBAYFTNTGOOGBSXLIIPLTR
      These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results
      Oct 29BenzingaBSX
      Oppenheimer downgrades Boston Scientific stock rating on growth concerns
      Oct 29Investing.comBSX
      Mizuho cuts Boston Scientific stock price target on growth outlook
      Oct 29Investing.comBSX
      Boston Scientific (BSX) Could Be 27% Below Fair Value After Earnings Guidance Cut

      Boston Scientific (BSX) moved into focus after third quarter 2026 results, as modest sales of US$5.14b and net income of US$582m met a sharply lower market reaction and fresh earnings guidance. The sharp 1-day share price decline of 5.84% brings Boston Scientific to US$42.43, capping a weak run in which the share price return is down 7.76% over 90 days and the 1-year total shareholder return has fallen 57.70%. This suggests sentiment has faded as investors reassess risk after the cyberattack,...

      Oct 29Yahoo FinanceBSX
      Canaccord lowers Boston Scientific stock price target on delayed product launches
      Oct 29Investing.comBSX
      BSX Stock Looks To Snap 3-Week Winning Streak: Analysts Downgrade Boston Scientific As Cyberattack And Slowing Growth Cloud Outlook
      Oct 29Yahoo FinanceBSX
      Boston Scientific Q3 Earnings Call Highlights
      Oct 29Yahoo FinanceBSX
      Boston Scientific (BSX) Stock Sinks As Q3 Results Deepen Margin Concerns
      Oct 29Yahoo FinanceBSX

      This is the newest page. Registered accounts read further back.